Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Dr. Lilge OSA Webinar - Aug. 18

<< Previous

Bullboard Posts

Next >>

Comment by fredgoodwinsonon Jun 15, 2021 1:26pm

158 Views

Post# 33389175

RE:RE:Dr. Lilge OSA Webinar - Aug. 18

Thanks once again Eog. Your post gives us comfort that Dr.Lilge has resolved these complexities and that in parallel with non-GLP and GLP we have been put on track for x-ray activated Rutherrin in humans next year - a scenario that you correctly describe as ‘an oncological photodynamic therapy revolution’.

You’d scarcely think it from the current market in the stock but no matter. Your extraordinary surveillance more than makes up for the manipulation of the stock and the political b/s that those of us here for the science have to endure.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?